189 related articles for article (PubMed ID: 23192276)
21. Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
Hartman ML; Talar B; Sztiller-Sikorska M; Nejc D; Czyz M
Oncotarget; 2016 Feb; 7(8):9026-40. PubMed ID: 26824319
[TBL] [Abstract][Full Text] [Related]
22. The effect of micro-sized titanium dioxide on WM-266-4 metastatic melanoma cell line.
Prunk Zdravković T; Zdravković B; Lunder M; Ferk P
Bosn J Basic Med Sci; 2019 Feb; 19(1):60-66. PubMed ID: 30383985
[TBL] [Abstract][Full Text] [Related]
23. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
Touil Y; Zuliani T; Wolowczuk I; Kuranda K; Prochazkova J; Andrieux J; Le Roy H; Mortier L; Vandomme J; Jouy N; Masselot B; Ségard P; Quesnel B; Formstecher P; Polakowska R
Stem Cells; 2013 Apr; 31(4):641-51. PubMed ID: 23355370
[TBL] [Abstract][Full Text] [Related]
24. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
[TBL] [Abstract][Full Text] [Related]
25. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
26. Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
[TBL] [Abstract][Full Text] [Related]
27. Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.
Saeed MEM; Boulos JC; Machel K; Andabili N; Marouni T; Roth W; Efferth T
In Vivo; 2022; 36(4):1651-1666. PubMed ID: 35738589
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
30. Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
Liao K; Xia B; Zhuang QY; Hou MJ; Zhang YJ; Luo B; Qiu Y; Gao YF; Li XJ; Chen HF; Ling WH; He CY; Huang YJ; Lin YC; Lin ZN
Theranostics; 2015; 5(3):302-21. PubMed ID: 25553117
[TBL] [Abstract][Full Text] [Related]
31. Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
Czyz M; Lesiak-Mieczkowska K; Koprowska K; Szulawska-Mroczek A; Wozniak M
Br J Pharmacol; 2010 Jul; 160(5):1144-57. PubMed ID: 20590608
[TBL] [Abstract][Full Text] [Related]
32. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the roles of ABCB5 in normal and cancer cells.
Duvivier L; Gillet JP
Trends Cancer; 2022 Oct; 8(10):795-798. PubMed ID: 35907754
[TBL] [Abstract][Full Text] [Related]
35. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
36. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract][Full Text] [Related]
37. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms.
Moitra K; Scally M; McGee K; Lancaster G; Gold B; Dean M
PLoS One; 2011 Jan; 6(1):e16318. PubMed ID: 21298007
[TBL] [Abstract][Full Text] [Related]
38. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
[TBL] [Abstract][Full Text] [Related]
39. p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance.
Yang JY; Ha SA; Yang YS; Kim JW
BMC Cancer; 2010 Jul; 10():388. PubMed ID: 20649952
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Liu M; Yang Y; Liu D; Cao Y; Li Y
J Tradit Chin Med; 2020 Dec; 40(6):908-916. PubMed ID: 33258341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
